French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)

Bensadoun, René-Jean; Bénézery, Karen; Dassonville, Olivier; Magné, Nicolas; Poissonnet, Gilles; Ramaïoli, Alain; Lemanski, Claire; Bourdin, Sylvain; Tortochaux, Jacques; Peyrade, Frédéric; Marcy, Pierre-Yves; Chamorey, Emmanuel; Vallicioni, Jacques; Seng, Hang; Alzieu, Claude; Géry, Bernard; Chauvel, Pierre; Schneider, Maurice; Santini, José; Demard, François; Calais, Gilles

doi:10.1016/j.ijrobp.2005.09.041

« Previous Next »International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 983-994, 15 March 2006

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)

Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Atlanta, GA, Oct 3–7, 2004.

René-Jean Bensadoun, M.D.
- Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France
- Reprint requests to: René-Jean Bensadoun, M.D., Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189 Nice cedex 2, France. Tel: (+33) 4-9203-1270; Fax: (+33) 4-9203-1570
Karen Bénézery, M.D.
- Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France
Olivier Dassonville, M.D.
- Department of Head and Neck Surgery, Centre Antoine Lacassagne, Nice, France
Nicolas Magné, M.D., Ph.D.
- Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France
Gilles Poissonnet, M.D.
- Department of Head and Neck Surgery, Centre Antoine Lacassagne, Nice, France
Alain Ramaïoli, M.D.
- Department of Statistics Unit, Centre Antoine Lacassagne, Nice, France
Claire Lemanski, M.D.
- Centre Val d’Aurelle—Paul Lamarque, Montpellier, France
Sylvain Bourdin, M.D.
- Centre René-Gauducheau, Nantes, France
Jacques Tortochaux, M.D.
- Centre Jean-Perrin, Clermont-Ferrand, France
Frédéric Peyrade, M.D.
- Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
Pierre-Yves Marcy, M.D.
- Department of Radiology, Centre Antoine Lacassagne, Nice, France
Emmanuel Chamorey, Pharm.D.
- Department of Statistics Unit, Centre Antoine Lacassagne, Nice, France
Jacques Vallicioni, M.D.
- Department of Head and Neck Surgery, Centre Antoine Lacassagne, Nice, France
Hang Seng, M.D.
- Centre Henri-Becquerel, Rouen, France
Claude Alzieu, M.D.
- Institut Paoli-Calmettes, Marseille, France
Bernard Géry, M.D.
- Centre François-Baclesse, Caen, France
Pierre Chauvel, M.D.
- Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France
Maurice Schneider, M.D., Ph.D.
- Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
José Santini, M.D., Ph.D.
- Department of Otolaryngology, University Hospital, Nice, France
François Demard, M.D., Ph.D.
- Department of Head and Neck Surgery, Centre Antoine Lacassagne, Nice, France
Gilles Calais, M.D., Ph.D.
- Hôpital Jean Bretonneau, Tours, France

Received 6 May 2005; received in revised form 20 September 2005; accepted 27 September 2005. published online 23 December 2005.

To access this article, please choose from the options below

The French “Fédération Nationale des Centres de Lutte Contre le Cancer” (FNCLCC) promoted the present study in relation with the “Groupe d’Oncologie Radiothérapie Tête et Cou” (GORTEC).

PII: S0360-3016(05)02712-4

doi:10.1016/j.ijrobp.2005.09.041

« Previous Next »International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 983-994, 15 March 2006

Access this article on SciVerse ScienceDirect